Citius Pharma (CTXR) Video Presentation.

Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment for CoronaVirus and Acute Respiratory Distress. (This is not a vaccine folks, it...
Sorrento Theraputics, Biotech STock Review

Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.

LIVE QUOTE "Proof of Concept. We take note that Eli Lilly (LLY-Not Rated) reported yesterday'spositive interim results from a placebo-controlled trial of a similar compound...
aPHEX bIOcLEANSE

Hy-IQ Trademark

REGISTERED 9-15-2020
Inovie, Biotech Stock Review

Shorts Set $1.00 Price Target on Inovio (INO) $9.20.

Interesting battle brewing! LIVE CHART Inovio shares tumble 8% after short seller Muddy Waters says don't believe the COVID-19 vaccine hype (MarketWatch). Inovio Pharmaceuticals Inc. shares INO, -6.19% slid...

Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...

American Chemical Society May 2020. Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...

‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus patients (Miami Herald)

BY BEN CONARCK APRIL 16, 2020 A team of doctors at the University of Miami won emergency federal approval to use stem cell therapy on...
Fletcher Robbe

Dalrada (DFCO) Legal Counsel

CONTINUOUSLY UPDATED Dalrada Financial Adds Robbe to Board of DirectorsDalrada Financial Corporation Hires Fletcher Robbe International Dalrada Financial Adds Robbe to Board of Directors HENDERSON, Nev., Aug....

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...